- Home
- SINT vs SPRB Comparison
SINT vs SPRB Comparison
Compare SINT & SPRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- SPRB
- Stock Information
- Founded
- SINT 1996
- SPRB 2014
- Country
- SINT United States
- SPRB United States
- Employees
- SINT N/A
- SPRB N/A
- Industry
- SINT Medical/Dental Instruments
- SPRB Medicinal Chemicals and Botanical Products
- Sector
- SINT Health Care
- SPRB Health Care
- Exchange
- SINT Nasdaq
- SPRB Nasdaq
- Market Cap
- SINT 4.8M
- SPRB 5.5M
- IPO Year
- SINT 2014
- SPRB 2020
- Fundamental
- Price
- SINT $2.56
- SPRB $0.13
- Analyst Decision
- SINT Strong Buy
- SPRB Hold
- Analyst Count
- SINT 1
- SPRB 5
- Target Price
- SINT $30.00
- SPRB $1.75
- AVG Volume (30 Days)
- SINT 85.7K
- SPRB 2.6M
- Earning Date
- SINT 05-12-2025
- SPRB 04-15-2025
- Dividend Yield
- SINT N/A
- SPRB N/A
- EPS Growth
- SINT N/A
- SPRB N/A
- EPS
- SINT N/A
- SPRB N/A
- Revenue
- SINT $2,887,000.00
- SPRB $4,911,000.00
- Revenue This Year
- SINT N/A
- SPRB N/A
- Revenue Next Year
- SINT N/A
- SPRB $312.50
- P/E Ratio
- SINT N/A
- SPRB N/A
- Revenue Growth
- SINT 9.90
- SPRB N/A
- 52 Week Low
- SINT $1.71
- SPRB $0.12
- 52 Week High
- SINT $45.60
- SPRB $0.87
- Technical
- Relative Strength Index (RSI)
- SINT 52.90
- SPRB 25.68
- Support Level
- SINT $1.72
- SPRB $0.11
- Resistance Level
- SINT $2.78
- SPRB $0.32
- Average True Range (ATR)
- SINT 0.22
- SPRB 0.03
- MACD
- SINT 0.11
- SPRB -0.01
- Stochastic Oscillator
- SINT 73.83
- SPRB 14.51
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).